1 Min Read
Nov 13 (Reuters) - XBRANE BIOPHARMA AB:
* Q3 EBITDA LOSS SEK 8.2 MILLION VERSUS LOSS SEK 8.4 MILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.